Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study

Table 2

Change from baseline at week 12 for primary efficacy (FBG and PPG) measures.

	Baseline	Endpoint	Mean change from baseline (95% CI)	value
FBG (mmol/L)	n = 14085	n = 7162	−0.39 (−0.45, −0.34)	<0.001
	8.89 ± 2.12	8.39 ± 2.19
PPG (mmol/L)	n = 14085	n = 4653	−0.79 (−0.68, −0.89)	<0.001
	10.78 ± 3.35	9.76 ± 3.12

Unless indicated otherwise, data are presented as mean ± SD. CI, confidence interval; FBG, fasting blood glucose; n, number of patients; PPG, postprandial glucose.